The Valens (VLNS) Stock Analysis

What The Valens does

The Valens Company Inc. is a Canadian-headquartered enterprise with international reach, focused on the development, manufacturing, and sale of cannabinoid-based products. Its product portfolio encompasses dried cannabis and hemp biomass, alongside a wide array of consumer goods such as tinctures, two-piece caps, soft gels, oral sprays, vape pens, beverages, diverse concentrates, topicals, edibles, and natural health products. Additionally, Valens provides a comprehensive suite of services, including various extraction techniques (CO2, ethanol, hydrocarbon, solvent-less, and terpene), analytical testing, formulation, product development, and custom manufacturing. The company, formerly known as Valens Groworks Corp., officially changed its name to The Valens Company Inc. in June 2020.

Key metrics

ETFs linked to VLNS

Broad-market and Healthcare sector ETFs an investor holding The Valens is often also exposed to. Open an ETF page to see its actual top holdings.

PortView Portfolio Insights

PortView analyzes how VLNS fits your actual portfolio — position weight, portfolio concentration, unrealized gain/loss, contribution to return, sector exposure, indirect exposure through the ETFs you hold, and correlation with your other holdings. Connect a portfolio to see your personalized figures; PortView never shows another user's private holdings.

Similar companies

Frequently asked questions

What is the ticker symbol for The Valens?

The Valens trades under the ticker VLNS on NASDAQ.

Which exchange is VLNS listed on?

VLNS is listed on NASDAQ.

What sector does The Valens operate in?

The Valens is classified in the Healthcare sector (Drug Manufacturers - Specialty & Generic industry).

How can PortView help analyze VLNS in a portfolio?

PortView shows VLNS's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.